Table 1.

Proportion of PD-1^hiTim-3⁻ and PD-1^intTim-3⁻ cells in CD8⁺ and CD4⁺ effector TIL.

	CD8+	CD4+CD25lo/−
PD-1hiTim-3−	7.67 ± 3.75% (3.23%∼14.8%)	6.68 ± 3.08% (3.43%∼11.6%)
PD-1intTim-3−	24.39 ± 7.11% (12.2%∼37.6%)	30.90 ± 9.44% (18.67%∼52.63%)